Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Gynecologic 1

Conditions

Ovarian Neoplasms 4Peritoneal Neoplasms 1Pelvic Neoplasms 1Lung Neoplasms 1Head and Neck Neoplasms 1Gastrointestinal Neoplasms 1Endometrial Neoplasms 1

Interventions

Radiotherapy 4Surveys and Questionnaires 3Specimen Handling 2Iohexol 2Gemcitabine 2spartalizumab 1sodium thiosulfate 1serotonin adipinate 1liposomal doxorubicin 1X-Rays 1Watchful Waiting 1Vorinostat 1Surgical Procedures, Operative 1Sunitinib 1Solutions 1Serotonin 1Saline Solution 1Re-Irradiation 1Radiotherapy, Image-Guided 1Radiosurgery 1Probiotics 1Platinum 1Particle Accelerators 1Pafolacianine 1Paclitaxel 1Magnetic Resonance Spectroscopy 1Magnetic Resonance Imaging 1Lidocaine 1Ketamine 1Injections 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pelvic Neoplasms × Pafolacianine × Gynecologic × Clear all
NCT06915727 2026-04-01

An Imaging Agent (Pafolacianine) for Identifying Lesions in Pediatric Patients With Primary or Metastatic Solid Tumors

Mayo Clinic

Phase 3 Recruiting
20 enrolled
GynecologicHead & Neck

Head and Neck Neoplasms, Pelvic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡